The Veterinary Anti Infectives Market is destined to reach US$ 368 Million at a CAGR of 4.1% between 2025. The healthcare vertical is moving the gadget-way. The current scenario is such that one need not make appointments for weeks/months for being treated. The real-time diagnosis and course of treatment could be possible. This simultaneous monitoring and treatment are bound to take the healthcare industry by storm in the next 10 years.
In recent years, reports of deadly animal disease outbreaks have become more recurrent. These diseases are not only a threat to the existence of many wild species but also lead to substantial livestock losses.
The prevention and treatment of such diseases are key market indicators for veterinary therapeutics including veterinary anti-infectives. In its latest report, Persistence Market Research has projected that the global veterinary anti-infectives market will expand at a CAGR of 4.1% over the forecast period (2017–2025) and reach a valuation of US$ 5,221.2 Mn by 2025-end.
Get Going With Sample Of Veterinary Anti Infectives Market Report! https://www.persistencemarketresearch.co/samples/17014
- Bayer AG
- Cipla Limited
- Dechra Pharmaceuticals PLC
- Eli Lilly and Company (Elanco Animal Health)
- Heska Corp (Diamond Animal Health)
- Merck & Co., Inc. (Merck Animal Health)
- Neogen Corporation
- Phibro Animal Health Corporation
- Sanofi (Merial Animal Health)
- Vetoquinol S.A.
- Virbac S.A.
- Zoetis, Inc.
- Boehringer Ingelheim GmbH
- Ceva Santé Animale
- Indian Immunologicals Limited
- Intas Pharmaceuticals Limited
- Norbrook Laboratories Limited
- Zydus Animal Health Limited
- Ashish Life Science Private Limited
- Oceanic Pharmachem Private Limited.
Increasing demand for anti-microbial agents is expected to contribute significantly towards the growth of market revenue in the near future. The rise in livestock population can boost the demand for veterinary therapeutics globally.
In 2014, the Food and Agriculture Organization of the United Nations estimated the global cattle count at over 1.5 billion. These figures are further expected to grow substantially due to rapidly growing demand for livestock.
North America to Remain the Frontrunner in the Global Veterinary Anti-Infective Market
North America is currently the largest veterinary anti-infectives market and is estimated to represent 30.5% value share of the global market by 2025-end, expanding at CAGR of 3.7%.
This growth is primarily attributed to the increase in pet ownership and demand for high-quality meat in the U.S. and Canada. Meanwhile, Latin America will continue to be the second most attractive market during the forecast period. The market in Asia Pacific (APAC) is projected to witness the fastest growth over 2025.
Keeping A Tab On Key Players In The Veterinary Anti Infectives Market? Go To “Purchase Now” To Decipher The Competitive Analysis In Our Veterinary Anti Infectives Market Report! https://www.persistencemarketresearch.com/checkout/17014
Additional Highlights of the Report Include:
Based on species types, use of veterinary anti-infectives medicines is relatively higher on livestock animals as compared to pet animals. In 2016, livestock animals accounted for more than 68% market value share, however, this figure is likely to drop to 67.4% by 2025 end.
Antimicrobial agents currently are the most preferred drug type. By the end of forecast period, antimicrobial agents are expected to command for 54.6% value share of the market. Other drugs such as antifungal agents and antiviral agents are also gaining traction owing to product improvement and effectiveness.
Based on modes of administration, the oral route is presently the most common drug administration mode followed by the parenteral route. By the end of 2025, the oral administration segment is projected to reach a market valuation of US$ 1,573.1 Mn.
Veterinary clinics are projected to reaming the leading distribution channel for veterinary anti-infectives in 2017 and beyond. Of late, veterinary hospitals and pharmacies have emerged as the other two key distribution channels for various veterinary drugs including anti-infectives.
Access Trending Reports:
Hemoglobinopathy Market – Persistence Market Research analyzes the performance of the global hemoglobinopathy market over an eight-year period and provides insights on the key factors and trends likely to influence the market during the forecast period (2016 – 2024).
Allergy Shots Market – According to a latest report published by the PMR, the global allergy shots market is projected to be valued at US$ 1.5 Bn in 2020, and is expected to expand at a CAGR of around 6% during the forecast period (2020–2030).
Neurovascular Embolization Devices Market – The global neurovascular embolization devices market is expected to account for more than US$ 1,733.1 Mn, in terms of value, by 2028 end.
Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers’ experience by acting as the “missing” link between “customer relationships” and “business outcomes’. The best possible returns are assured therein.
Persistence Market Research
Address – 305 Broadway, 7th FloorNew York City,
NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – email@example.com
Website – https://www.persistencemarketresearch.com
Persistence Market Research Address – 305 Broadway, 7th Floor, New York City, NY 10007, United States U.S. Ph. – +1-646-568-7751 USA-Canada Toll-free – +1 800-961-0353